Abstract:Due to vigorous alloimmunity, an allograft is usually rejected without any conventional immunosuppressive treatment. However, continuous global immunosuppression may cause severe side effects, including tumors and infections. Mounting evidence has shown that cyclosporine (CsA), a common immunosuppressant used in clinic, impedes allograft tolerance by dampening regulatory T cells (Tregs), although it inhibits allograft rejection at the same time. Therefore, it is necessary to seek an alternative immunosuppressive drug that spares Tregs with high efficiency in suppression but low toxicity. In this study, we investigated the capacity of emodin, an anthraquinone molecule originally extracted from certain natural plants, to prolong transplant survival in a mouse model and explored the cellular and molecular mechanisms underlying its action. We found that emodin significantly extended skin allograft survival and hindered CD3(+) T cell infiltration in the allograft, accompanied by an increase in CD4(+)Foxp3(+) and CD8(+)CD122(+) Treg frequencies and numbers but a reduction in effector CD8(+)CD44(high)CD62L(low) T cells in recipient mice. Emodin also inhibited effector CD8(+) T cells proliferation in vivo. However, CD4(+)CD25(+), but not CD8(+)CD122(+), Tregs derived from emodin-treated recipients were more potent in suppression of allograft rejection than those isolated from control recipients, suggesting that emodin also enhances the suppressive function of CD4(+)CD25(+) Tregs. Interestingly, depleting CD25(+) Tregs largely reversed skin allograft survival prolonged by emodin while depleting CD122(+) Tregs only partially abrogated the same allograft survival. Furthermore, we found that emodin hindered dendritic cell (DC) maturation and reduced alloantibody production posttransplantation. Finally, we demonstrated that emodin inhibited in vitro proliferation of T cells and blocked their mTOR signaling as well. Therefore, emodin may be a novel mTOR inhibitor that suppresses alloimmunity by inducing both CD4(+)FoxP3(+) and CD8(+)CD122(+) Tregs, suppressing alloantibody production, and hindering DC maturation. Thus, emodin is a newly emerging immunosuppressant and could be utilized in clinical transplantation in the future.

Immunosuppressive Effects of Emodin: An In Vivo and In Vitro Study

Emodin Inhibits The Differentiation And Maturation Of Dendritic Cells And Increases The Production Of Regulatory T Cells

Immunosuppressive effects of emodin on skin transplantation in mice

Inhibitory Effects of Emodin on Proliferation of Human Lymphocytes in Vitro

Experimental study of promotion of Emodin on lymphocyte apoptosis

Corrigendum: A New Immunosuppressive Molecule Emodin Induces Both CD4+FoxP3+ and CD8+CD122+ Regulatory T Cells and Suppresses Murine Allograft Rejection

Emodin Induces Human T Cell Apoptosis in Vitro by ROS-mediated Endoplasmic Reticulum Stress and Mitochondrial Dysfunction

Immunosuppressive Activity of the Ethanol Extract of Sedum Sarmentosum and Its Fractions on Specific Antibody and Cellular Responses to Ovalbumin in Mice

Emodin Inhibits the Proliferation and Migration of B16F10 Cells and Induces Their Apoptosis

Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.

Emodin Inhibits LPS-induced Inflammatory Response by Activating PPAR-γ in Mouse Mammary Epithelial Cells.

Emodin Attenuates Acute Rejection of Liver Allografts by Inhibiting Hepatocellular Apoptosis and Modulating the Th1/Th2 Balance in Rats

Effects of Emodin on the Proliferation of the Glomerular Mesangial Cell and Correlative Cytokines in Rats

Emodin ameliorates lipopolysaccharide-induced mastitis in mice by inhibiting activation of NF-κB and MAPKs signal pathways.

Immunosuppressive effect of emodin on acute rejection after orthotopic liver transplantation in rats

Inhibitory effect of emodin on human hepatoma cell line SMMC-7721 and its mechanism

Emodin suppresses interleukin-1beta induced mesangial cells proliferation and extracellular matrix production via inhibiting P38 MAPK.

Network Pharmacology Combined with an Experimental Validation Study to Reveal the Effect and Mechanism of Eucommia ulmoides Leaf Polysaccharide against Immunomodulation

Emodin Improves Lipopolysaccharide‐Induced Microcirculatory Disturbance in Rat Mesentery

Emodin enhances osteogenesis and inhibits adipogenesis

Regulatory Effects Of Emodin On Nf-Kappa B Activation And Inflammatory Cytokine Expression In Raw 264.7 Macrophages